Establishment Labs Holdings annual ebitda
2021
2022
2023
2024
2025
Establishment Labs Holdings's calculated EBITDA was −$32.8M for fiscal 2025.
View full Establishment Labs Holdings company overview| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$32.8M | $12.5M | — |
| 2024 | 2024-12-31 | −$45.3M | $16.9M | — |
| 2023 | 2023-12-31 | −$62.2M | −$25.1M | — |
| 2022 | 2022-12-31 | −$37.2M | −$14.5M | — |
| 2021 | 2021-12-31 | −$22.6M | — | — |
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | −$4.9M | $10.4M | — |
| Q4 2025 | 2025-12-31 | −$2.4M | $14.6M | — |
| Q3 2025 | 2025-09-30 | −$2.5M | $9.3M | — |
| Q2 2025 | 2025-06-30 | −$12.5M | −$4.1M | — |
| Q1 2025 | 2025-03-31 | −$15.3M | −$7.4M | — |
| Q4 2024 | 2024-12-31 | −$17.1M | $4.1M | — |
| Q3 2024 | 2024-09-30 | −$11.8M | $8.5M | — |
| Q2 2024 | 2024-06-30 | −$8.4M | $4.7M | — |
| Q1 2024 | 2024-03-31 | −$7.9M | −$374,000 | — |
| Q4 2023 | 2023-12-31 | −$21.2M | −$8.9M | — |
| Q3 2023 | 2023-09-30 | −$20.3M | −$10.5M | — |
| Q2 2023 | 2023-06-30 | −$13.1M | −$3.3M | — |
| Q1 2023 | 2023-03-31 | −$7.6M | −$2.3M | — |
| Q4 2022 | 2022-12-31 | −$12.3M | −$4.4M | — |
| Q3 2022 | 2022-09-30 | −$9.8M | −$1.1M | — |
| Q2 2022 | 2022-06-30 | −$9.8M | −$5.5M | — |
| Q1 2022 | 2022-03-31 | −$5.3M | −$3.5M | — |
| Q4 2021 | 2021-12-31 | −$7.9M | −$5.5M | — |
| Q3 2021 | 2021-09-30 | −$8.7M | $668,000 | — |
| Q2 2021 | 2021-06-30 | −$4.3M | $3.2M | — |
| Q1 2021 | 2021-03-31 | −$1.8M | $6.8M | — |
| Q3 2020 | 2020-09-30 | −$2.4M | $6.8M | — |
| Q2 2020 | 2020-06-30 | −$9.4M | −$1.2M | — |
| Q1 2020 | 2020-03-31 | −$7.5M | −$1.7M | — |
| Q3 2019 | 2019-09-30 | −$8.5M | −$2.4M | — |
| Q2 2019 | 2019-06-30 | −$9.2M | −$6.5M | — |
| Q1 2019 | 2019-03-31 | −$8.2M | — | — |
| Q3 2018 | 2018-09-30 | −$5.8M | — | — |
| Q2 2018 | 2018-06-30 | −$6.2M | — | — |
| Q1 2018 | 2018-03-31 | −$2.7M | — | — |
Across the available reported history, Establishment Labs Holdings's ebitda increased from −$45.3M to −$32.8M, a change of $12.5M. The latest reported quarter, Q1 2026, shows −$4.9M.
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Establishment Labs Holdings filings at SEC.gov ↗